Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jiangxi Kelun Pharmaceutical Co., Ltd. is a prominent subsidiary of the Sichuan Kelun Pharmaceutical Group, serving as a major manufacturing and development hub within the organization. The company specializes in the production of large-volume parenteral solutions, including intravenous infusions in glass bottles, plastic bottles, and flexible plastic bags. In addition to its core IV fluid business, Jiangxi Kelun manufactures a diverse range of finished dosage forms such as tablets, capsules, and granules across various therapeutic categories including anti-infectives and cardiovascular health. The facility is GMP-certified and plays a vital role in the parent company's domestic and international supply chain, focusing on high-quality, large-scale pharmaceutical production.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jiangxi Kelun Pharmaceutical.